Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium
Year: 2015
Type: article
Study design: Observational Study
Abstract: Plasmablastic lymphoma (PBL) is an aggressive CD20 negative diffuse large B cell lymphoma over-represented in patients with HIV infection. CD45 expression is weak, but immunoglobulin genes are rear...
Authors: Ariela Noy, Shelly Y. Lensing, Page C. Moore, Neel Gupta, David Aboulafia, Richard Ambinder, Robert Baiocchi, Bruce J Dezube, David Henry, Lawrence Kaplan, Alexandra M. Levine, Ronald Mitsuyasu, Lee Ratner, Erin Reid, Scot Remick, Joseph Sparano, Dimitrios Tzachanis, William Wachsman, Amy Chadburn
Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, University of Arkansas for Medical Sciences, Virginia Mason Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The Ohio State University, Beth Israel Deaconess Medical Center, University of California, San Francisco, University of Southern California, University of California, Los Angeles, Washington University in St. Louis, University of California San Diego, Moores Cancer Center, West Virginia University, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Northwestern University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2221742072